Home > Healthcare > Biotechnology > Biotechnology R&D > Primary Cell Culture Market

Primary Cell Culture Market Size

  • Report ID: GMI9208
  • Published Date: Apr 2024
  • Report Format: PDF

Primary Cell Culture Market Size

Primary Cell Culture Market size was valued at around USD 5 billion in 2023 and is estimated to grow at 12.2% CAGR from 2024 to 2032. The market experienced significant growth driven by the increasing prevalence of chronic diseases such as cancer, infections, autoimmune disorders, diabetes mellitus, cardiovascular diseases, and nephrological conditions.

 

According to the latest estimates from the International Agency for Research on Cancer (IARC) in 2022, there were approximately 20 million new cancer cases projecting a rise of over 35 million new cancer cases by 2050, reflecting a substantial 77% increase from the estimated cases in 2022. This upward trend in cancer incidence globally is expected to drive demand for new therapeutics and personalized medicines. Therefore, as researchers strive to develop tailored treatments for such diseases, primary cell culture techniques become essential for modeling patient-specific responses and understanding disease mechanisms at the cellular level. This need for precision in drug discovery and development fuels the adoption of primary cell culture methodologies, thereby boosting market growth.
 

Primary cell culture involves the propagation of cells directly isolated from living tissues, including diverse cell types including human or animal cells. Cultured in specialized media, these cells require precise environmental conditions, including nutrients, growth factors, and supplements tailored to their specific requirements. The cell culture media compositions vary widely, providing essential nutrients, pH buffering, and growth-promoting factors crucial for cell survival, proliferation, and functionality, facilitating various biomedical and biotechnological research applications.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The primary cell culture market size was valued at USD 5 billion in 2023 and will grow at 12.2% CAGR from 2024 to 2032, driven by the increasing prevalence of chronic diseases

The reagents and supplements component segment held 41.4% of the primary cell culture industry share in 2023, owing to their routine utilization in both research and manufacturing involving primary cell culture.

U.S. primary cell culture market accounted for 90.5% share in 2023 and will grow rapidly till 2032, driven by a well-established regulatory framework supporting biopharmaceutical innovation.

BioLamina AB, Corning Incorporated, Creative Bioarray, Cyagen, FUJIFILM Wako Pure Chemical Corporation, Kosheeka, Lifeline Cell Technology, Lonza Bioscience, Merck KGaA, PELOBIOTECH GmbH, and PromoCell GmbH among others.

Primary Cell Culture Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 13
  • Tables & Figures: 396
  • Countries covered: 22
  • Pages: 190
 Download Free Sample